UstekinumabAgricultural BiotechnologyUpdated on May 7, 2020 View more like this | Visit SHIRLEY, NY | Contact Bella Smith |

Recombinant monoclonal antibody to IL12+IL23. Ustekinumab (INN, experimental name CNTO 1275, proprietary commercial name Stelara, Centocor) is a human monoclonal antibody. It is directed against interleukin 12 and interleukin 23, naturally occurring proteins that regulate the immune system and immune-mediated inflammatory disorders.